Zong S - Search Results

1

Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect.

Zhang Q, Qin Y, Zhao J, Tang Y, Hu X, Zhong W, Li M, Zong S, Li M, Tao H, Zhang Z, Chen S, Liu H, Yang L, Zhou H, Liu Y, Sun T, Yang C. Zhang Q, et al. Among authors: zong s. Cell Death Dis. 2019 Jan 17;10(2):43. doi: 10.1038/s41419-018-1282-6. Cell Death Dis. 2019. PMID: 30674871 Free PMC article.

2

Protease-activated receptor-1 (PAR1) promotes epithelial-endothelial transition through Twist1 in hepatocellular carcinoma.

Xiao T, Zhang Q, Zong S, Zhong WL, Qin Y, Bi Z, Chen S, Liu HJ, Wei JJ, Zhou BJ, Wang LM, Zhou HG, Liu YR, Sun T, Yang C. Xiao T, et al. Among authors: zong s. J Exp Clin Cancer Res. 2018 Aug 6;37(1):185. doi: 10.1186/s13046-018-0858-4. J Exp Clin Cancer Res. 2018. PMID: 30081924 Free PMC article.

3

Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.

Xiao T, Zhong W, Zhao J, Qian B, Liu H, Chen S, Qiao K, Lei Y, Zong S, Wang H, Liang Y, Zhang H, Meng J, Zhou H, Sun T, Liu Y, Yang C. Xiao T, et al. Among authors: zong s. Cell Death Dis. 2018 Sep 5;9(9):906. doi: 10.1038/s41419-018-0902-5. Cell Death Dis. 2018. PMID: 30185783 Free PMC article.

4

Correction: Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect.

Zhang Q, Qin Y, Zhao J, Tang Y, Hu X, Zhong W, Li M, Zong S, Li M, Tao H, Zhang Z, Chen S, Liu H, Yang L, Zhou H, Liu Y, Sun T, Yang C. Zhang Q, et al. Among authors: zong s. Cell Death Dis. 2022 Feb 9;13(2):134. doi: 10.1038/s41419-022-04557-7. Cell Death Dis. 2022. PMID: 35140197 Free PMC article. No abstract available.

5

Oleanolic Acid Inhibits Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Promoting iNOS Dimerization.

Wang H, Zhong W, Zhao J, Zhang H, Zhang Q, Liang Y, Chen S, Liu H, Zong S, Tian Y, Zhou H, Sun T, Liu Y, Yang C. Wang H, et al. Among authors: zong s. Mol Cancer Ther. 2019 Jan;18(1):62-74. doi: 10.1158/1535-7163.MCT-18-0448. Epub 2018 Oct 8. Mol Cancer Ther. 2019. PMID: 30297361

6

Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer.

Liu Y, Zhao J, Zhao Y, Zong S, Tian Y, Chen S, Li M, Liu H, Zhang Q, Jing X, Sun B, Wang H, Sun T, Yang C. Liu Y, et al. Among authors: zong s. J Cell Mol Med. 2019 Feb;23(2):750-760. doi: 10.1111/jcmm.13897. Epub 2018 Nov 24. J Cell Mol Med. 2019. PMID: 30472806 Free PMC article.

7

Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters.

Liu YR, Liang L, Zhao JM, Zhang Y, Zhang M, Zhong WL, Zhang Q, Wei JJ, Li M, Yuan J, Chen S, Zong SM, Liu HJ, Meng J, Qin Y, Sun B, Yang L, Zhou HG, Sun T, Yang C. Liu YR, et al. Among authors: zong sm. Oncotarget. 2017 May 2;8(32):52901-52912. doi: 10.18632/oncotarget.17548. eCollection 2017 Aug 8. Oncotarget. 2017. PMID: 28881781 Free PMC article.

8

Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition.

Liu YR, Sun B, Zhu GH, Li WW, Tian YX, Wang LM, Zong SM, Sheng PZ, Li M, Chen S, Qin Y, Liu HJ, Zhou HG, Sun T, Yang C. Liu YR, et al. Among authors: zong sm. Toxicol Appl Pharmacol. 2018 Dec 1;360:1-8. doi: 10.1016/j.taap.2018.09.019. Epub 2018 Sep 18. Toxicol Appl Pharmacol. 2018. PMID: 30240696

9

Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins.

Zhou B, Zong S, Zhong W, Tian Y, Wang L, Zhang Q, Zhang R, Li L, Wang W, Zhao J, Chen X, Feng Y, Zhai B, Sun T, Liu Y. Zhou B, et al. Among authors: zong s. Oncogene. 2020 Feb;39(7):1527-1542. doi: 10.1038/s41388-019-1082-1. Epub 2019 Nov 1. Oncogene. 2020. PMID: 31676872

10

Corrigendum to "Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition" [Toxicol Appl Pharmacol 360 (2018) 1-8].

Liu YR, Sun B, Zhu GH, Li WW, Tian YX, Wang LM, Zong SM, Sheng PZ, Li M, Chen S, Qin Y, Liu HJ, Zhou HG, Sun T, Yang C. Liu YR, et al. Among authors: zong sm. Toxicol Appl Pharmacol. 2022 Jan 15;435:115824. doi: 10.1016/j.taap.2021.115824. Epub 2021 Dec 8. Toxicol Appl Pharmacol. 2022. PMID: 34890639 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

635 results

Search Page